CASE PhD: Development of a Human-Engineered Skeletal Muscle Contractility Assay

CASE PhD: Development of a Human-Engineered Skeletal Muscle Contractility Assay

Quick Decision

Can a laboratory-grown human muscle model reveal how muscle performs while shortening and lengthening, rather than only how much force it produces at a fixed length? This CASE doctorate at Coventry connects tissue-model development, dynamic mechanical assessment and pharmaceutical effects. Its particular attraction is the combination of muscle physiology with an explicitly named industrial partner, Myomakers Ltd, within the MIBTP training network.

Strong but verify fit. The project has concrete experimental and analytical work, although Coventry's overall university ranking is modest. Its value rests on the research question, supervisory expertise and industry-linked training. The saved official deadline is 23 November 2026, for the CASE programme's October 2027 entry; no closing clock or timezone was verified. A complete competitive international funding route is published: UKRI Home fees and maintenance, plus Coventry funding for the international fee difference. Up to 30% of awards in the stated cohort may go to international applicants; the information does not confirm whether the cohort spans the full MIBTP partnership or give a project-specific award count. This is not an individual award probability. Before preparing an application, establish qualification equivalence and how the academic and industrial strands would be supervised.

Research Problem and Doctoral Work

From an engineered tissue to a meaningful functional measurement

Skeletal muscle produces force and mechanical work. Isometric, concentric and eccentric actions examine different aspects of performance; an endpoint measured at a fixed length does not necessarily describe dynamic behaviour. Tissue engineering makes human muscle models available for preclinical research, but a model's existence does not establish that it faithfully measures these functions.

The advertised doctorate has three connected tasks. First, improve tissue-engineering approaches to obtain a functional model suitable for contractile assessment. Second, establish and evaluate work-loop assessment of dynamic function and compare models of muscle ageing. Third, use the resulting human engineered-muscle assay to examine pharmaceutical effects on contractile performance for myotoxicity research. The advertised claim to develop a first assay is a research ambition, rather than a verified priority or completed result. Exact CASE project

A work loop relates force to length change over a contraction cycle, allowing mechanical work and power to be considered alongside force. The important doctoral question is whether the assay separates biological differences from differences created by the model or measurement. The project description does not identify a final cell source, ageing model, pharmaceutical panel, validated reference dataset or performance threshold. These choices should become a bounded research plan with the supervisors, not be inferred from methods mentioned in earlier papers.

Useful comparisons and limits

Three distinctions could guide a discussion of research quality. An engineered model should first demonstrate an interpretable functional phenotype, rather than be judged solely by morphology or molecular markers. Dynamic measurements should then be compared with isometric measures without assuming that both rank models identically. Finally, a pharmaceutical response needs to be distinguished from baseline differences, model variability and measurement uncertainty. These are analytical suggestions, not additional advertised experiments or instructions for conducting them.

Repeatability within a model, reproducibility across independent preparations and the relevance of a comparator are different questions. The ageing strand also requires clarity about what aspect of ageing the model represents. A response in an engineered preparation would not alone establish a patient's benefit, a human safety margin or regulatory acceptance. The proposed work could help reduce reliance on animal studies, but neither the advertisement nor the reviewed papers establishes an entirely animal-free research programme.

School, Field and Doctoral Training

Coventry University, United Kingdom, is the university of registration. Warwick hosts the MIBTP website; the partnership does not establish a joint degree. The exact public Coventry application identifies course code DLSR002, research area Clinical Sciences and Translational Medicine. The relevant centre is now called Centre for Discoveries in Life Sciences, while some links and application categories retain the earlier Health and Life Sciences name. Public project application

The centre combines cell biology, pharmacology, biochemistry, metabolic physiology and biotechnology, and reports Royal Society of Biology doctoral-training accreditation. This is a training-quality statement, not a muscle-research ranking. QS lists Coventry joint 581st overall in 2027, versus 558th in 2026; a relevant current subject ranking was not verified. The institutional name should therefore carry less weight than the specific research support and placement arrangements. Centre overview

The CASE scheme offers cohort teaching, transferable skills and a three-month research mini-project at a non-home institution between January and August of year one. Its industry placement is three to eighteen months, potentially divided into shorter periods. The advertised programme has up to twelve CASE studentships across projects; this is not twelve places on this topic. CASE training and placements

MIBTP describes a four-year programme. Its detailed published outline is labelled 2025: R programming and statistics, later bioinformatics and modelling, communication, ethics, masterclasses and annual development-needs reviews. It provides useful context, but is not a confirmed 2027 calendar. Generic PIPS requirements should not be added automatically to the CASE placement as a second compulsory placement. Coventry's Doctoral and Researcher College supports annual progress review, thesis submission and viva processes. Exact registration deadlines, the student's paid months and any extension terms require confirmation; the programme outline alone does not settle these. Published training outline

Supervisors, Original Research and Industry

Complementary expertise, with resources still to allocate

The retained staff profile lists Mark C. Turner as an Assistant Professor at Coventry. His research concerns muscle metabolism, human and cell models, and adaptation in health and disease; his background includes skeletal-muscle tissue engineering. Jason Tallis is an Associate Professor, with explicit expertise in work-loop mechanics and age-related muscle performance. These saved titles are more informative than retaining only the advertisement's “Dr” labels. Turner profile, Tallis profile

The official CASE page additionally names Professor Mark Lewis and Dr Andrew Capel, both associated there with Myomakers Ltd, and Professor Helen Maddock. The company website uses the brand Myomaker Bio and describes preclinical contract research and screening in muscle models. This is a specific industry connection, not evidence that the doctoral assay already has regulatory approval, a reserved client dataset or a commercial endpoint. Supervision time, equipment access, technical support, ownership and publication arrangements remain important interview questions.

Three recent formal original studies

Shelley, James and Tallis: 2024 dynamic mechanics

The effects of muscle starting length on work loop power output of isolated mouse soleus and extensor digitorum longus muscle — 2024, Journal of Experimental Biology 227(8), jeb247158, DOI 10.1242/jeb.247158. Ordered authors: Sharn P. Shelley; Rob S. James; Jason Tallis. The complete primary abstract reports muscle-specific relationships between starting length, dynamic power and passive work. Its relevance is methodological: static force–length results cannot simply stand in for dynamic performance. Tallis is third of three; correspondence and individual contributions were not verified. Isolated mouse muscles do not validate the proposed engineered human assay. Indexed April date fields differ, so only the verified publication year is used here. Primary record

Shelley and colleagues: 2025 muscle-specific responses

Adverse effects of high-fat diet consumption on contractile mechanics of isolated mouse skeletal muscle are reduced when supplemented with resveratrol — Journal of Physiology 603(9), 2675–2698, early online 11 May 2025, DOI 10.1113/JP287056. Ordered authors: Sharn P. Shelley; Rob S. James; Steven J. Eustace; Mark C. Turner; Ryan Brett; Emma L. J. Eyre; Jason Tallis. The complete institutional primary abstract combines isometric, dynamic power, fatigue and SIRT1 measurements in isolated mouse muscles. Effects differed between muscles, and SIRT1 did not explain the functional pattern. Turner is fourth and Tallis seventh; correspondence and individual contributions remain unverified. This supports careful interpretation of several endpoints, not a nutritional treatment recommendation or human assay validation. Institutional original

Brett, Hodson, Renshaw and Turner: 2026 model characterisation

Effects of culture media glucose concentration on LHCN-M2 skeletal muscle cell viability, differentiation and metabolic phenotype: a proof-of-concept study — 30 March 2026, Journal of Muscle Research and Cell Motility 47(2), article 11, DOI 10.1007/s10974-026-09729-y. Ordered authors: Ryan Brett; Leanne Hodson; Derek Renshaw; Mark C. Turner. The complete institutional primary abstract examines viability, proliferation, ATP production and differentiation in a human muscle cell line, while leaving broader metabolic implications for further work. Turner is fourth and the publisher explicitly identifies him as corresponding author; selected contribution statements include shared conceptualisation, funding, analysis and writing. This offers model-characterisation experience, but does not demonstrate dynamic force generation or an ageing assay. Institutional original

The three paper accounts are bounded by complete primary abstracts and ordered bylines, with publication details and the partial 2026 contribution statement identified above. They do not cover complete Methods–Results–Conclusions texts or supplementary material, and none of the separate studies demonstrates the proposed combined platform.

Funding, Fees and Living Costs

A complete competitive route, with personal terms outstanding

MIBTP Coventry instructions explicitly combine UKRI Home tuition and maintenance with Coventry funding for the international fee difference. Up to 30% of awards in the stated cohort may go to international applicants; the information does not confirm whether the cohort spans the full MIBTP partnership or give a project-specific award count. This is not an individual award probability. The published £21,805 annual stipend is for 2026/27, not a confirmed 2027 rate. Conference/travel and consumables budgets and laptop use are programme resources, rather than extra personal income or a promised computer gift. Coventry funding instructions

The applicant must fund travel to the UK, visa and associated costs, and the healthcare surcharge. The recorded government fee figures are £558 for the Student visa and £776 per visa year for student IHS; the visa can exceed course length. The programme's approximate £3,600 should not be treated as a fixed 2027 invoice. Cross-institution training and the industrial placement also require clarification about travel support and possible overlapping accommodation.

Coventry’s fee table is labelled 2026/27: PhD annual full-time fees are £5,238 Home / £16,500 overseas, with £2,619 / £8,300 part-time figures. These are not 2027 fees or evidence that a part-time CASE award is available. The table notes possible project bench fees; the actual studentship's research-cost responsibilities should be confirmed rather than presumed payable personally. Exact paid months, renewal and extension coverage belong in the offer. Dated research fees

Dated budget examples

Published 2026/27 postgraduate halls examples include £162 or £226 weekly on fifty-week contracts, corresponding to £8,100 or £11,300. Heating, lighting, water and contents insurance are included according to the accommodation page; room availability and 2027 prices remain unknown. A fifty-week contract also leaves two weeks outside a full-year comparison. Accommodation prices

The university's illustrative student scenarios are explicitly dated January 2025. One example allocates £60 weekly to food, £4 to a gym, £3 to a phone and £20 monthly to social activity. Those items total £3,724 over fifty-two weeks. Combining them with fifty-two weeks of the two rent examples gives £12,148–15,476. This mixes dated inputs for illustration and omits other personal, travel and placement costs. It is neither a 2027 quotation nor a prediction of stipend surplus. Dated living-cost scenarios

Eligibility and Application

MIBTP normally accepts a relevant first-class or high 2:1 degree. A low 2:1 plus a relevant Master's or at least three years postgraduate experience may qualify; a 2:2 or below is considered only with exceptional additional experience. Coventry's doctoral rules separately describe relevant 2:1 and project-mark requirements and Master's-merit alternatives. UK “60%” conditions must not be converted into a Chinese undergraduate cutoff. Individual overseas equivalence remains an admissions assessment.

The entry categories, still under the earlier centre name, list IELTS 7.0 overall, at least 6.5 each, or old-scale TOEFL iBT 95, at least 21 each, with two-year validity. Confirm the renamed DLS centre category and treatment of the newer TOEFL scale. The FAQ permits English evidence later in the process but still names October 2026 in that clause; it should not be silently rewritten as an authoritative 2027 date. Research entry conditions

Relevant cell biology or physiology, quantitative reasoning, measurement uncertainty and reproducible analysis would be useful preparation. The project does not state that applicants must already independently run its proposed assay. An example showing how an experimental comparison was interpreted would help explain research interests without inventing a required portfolio.

Follow the official Coventry table to the exact DLSR002 project, clearly state CASE and its title, and complete the separate ED&I form. The FAQ asks for CV, cover letter and references, with at least one academic reference and a professional alternative if a second academic referee cannot be sourced. Final portal fields and word limits behind login were not inspected. CASE interviews may run January–March, separately from the standard programme schedule; individual dates are unconfirmed. MIBTP application FAQ

Career Context

The 2025 UK alternative-methods strategy emphasises development, validation and uptake, supporting the relevance of work on human-relevant preclinical models. ABPI/EY's 2025 industry report also describes persistent physiological-modelling skills needs, alongside data and commercial skills and barriers to talent mobility. These are field-level signals, not a count of suitable vacancies or a guarantee of a job, salary or immigration route. Myomaker's contract-research setting makes evidence quality and a clear context of use particularly relevant.

Next Questions

Before applying: resolve personal degree and English requirements, confirm the deadline's closing details and prepare the exact Coventry CASE application and EDI.

At interview: establish the existing platform, what the ageing comparison represents, suitable validation criteria, supervisory responsibilities and the placement plan.

Before accepting: obtain written full international fee and maintenance terms, paid months and extension rules, research and mobility costs, and ownership/publication conditions. Scientific enquiries can be directed to Mark C. Turner at ad3759@coventry.ac.uk; contact is distinct from the formal application.

Evidence and Sources

Programme, supervisory, publication and financial details retain the dates and scope stated in their sections; they do not confirm current acceptance, individual eligibility, current prices or 2027 charges. The 2025 training outline, 2026/27 tuition, stipend and accommodation figures, January 2025 budget, and saved visa/IHS rates are not 2027 quotations.

Project, institution and training

• Exact CASE project and supervisors
• Industrial CASE programme
• MIBTP application and Coventry funding
• MIBTP FAQ
• Published 2025 training outline
• Mark Turner profile
• Jason Tallis profile
• Centre for Discoveries in Life Sciences
• Exact Coventry project application
• QS official Coventry ranking series
• Coventry official contact and country
• Doctoral and Researcher College

Original research and professional context

• 2024 starting-length original
• 2025 muscle-mechanics original
• 2026 human-cell-model original
• Myomaker Bio
• UK alternative-methods strategy
• ABPI/EY 2025 talent and skills report

Entry, costs and immigration

• Research entry criteria
• Dated postgraduate research fees
• Accommodation fees
• Dated living-cost scenarios
• Student visa
• Student healthcare surcharge